Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.

Thomas P LodiseJingyi LiHitesh N GandhiGerald O'BrienSanjay Sethi

Published in: International journal of chronic obstructive pulmonary disease (2020)

There is likely a clinically important intraclass difference in the risk of pneumonia between fluticasone- and budesonide-containing inhaled medications in COPD.

Keyphrases

chronic obstructive pulmonary disease
lung function
cystic fibrosis
community acquired pneumonia
respiratory failure
case control